Induction therapy for elderly patients with acute myeloid leukemia
- 30 November 2008
- journal article
- Published by Elsevier BV in Blood Reviews
- Vol. 22 (6), 311-320
- https://doi.org/10.1016/j.blre.2008.04.004
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- High CR-Rate after Intensive Chemotherapy but Disappointing Results after Palliative Treatment in Patients with Acute Myeloid Leukemia Above the Age of 60 Years: An Analysis of the AML97#38 Study of the East German Hematology and Oncology Study Group (OSHO).Blood, 2007
- High Relapse Rate of Acute Myeloid Leukemia with Translocation (8;21) or Inversion (16) in Elderly Patients Treated with Conventional Chemotherapy.Blood, 2007
- Decision Criteria for the Futility of Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML).Blood, 2007
- Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy:results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trialBlood, 2007
- Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older PatientsJournal of Clinical Oncology, 2007
- A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatmentCancer, 2007
- Age and acute myeloid leukemiaBlood, 2006
- Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:Cancer, 2006
- The outcomes and costs of acute myeloid leukemia among the elderly.Archives of Internal Medicine, 2002
- On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.Journal of Clinical Oncology, 1989